No Data
Express News | Cantor Fitzgerald Reiterates Overweight on Ultragenyx Pharmaceutical, Maintains $115 Price Target
Sector Update: Health Care Stocks Rise Premarket Wednesday
Health care stocks rose in Wednesday's premarket hours with the Health Care Select Sector SPDR Fund (XLV) advancing by 0.3% and the iShares Biotechnology ETF (IBB) 0.7% higher recently. Ultragenyx Pha
Express News | Mereo BioPharma Shares Are Trading Higher After the Company and Ultragenyx Pharmaceutical Announced 14-month Results From the Phase 2 Portion of the Ongoing Phase 2/3 Orbit Study
Sector Update: Health Care
Health care stocks rose in Wednesday's premarket hours with the Health Care Select Sector SPDR Fund (XLV) advancing by 0.5% and the iShares Biotechnology ETF (IBB) 1.1% higher recently. Ultragenyx Pha
Stifel Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $127
Stifel analyst Dae Gon Ha maintains $Ultragenyx Pharmaceutical(RARE.US)$ with a buy rating, and maintains the target price at $127.According to TipRanks data, the analyst has a success rate of 37.9% a
Wells Fargo Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $72
Wells Fargo analyst Tiago Fauth maintains $Ultragenyx Pharmaceutical(RARE.US)$ with a buy rating, and maintains the target price at $72.According to TipRanks data, the analyst has a success rate of 39